AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY'S TIMETABLE FOR EXAMINATION OF THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS BASED ON THE UPDATED TIMETABLE, A DECISION FROM THE …